Abstract
Despite treatment guidelines recommending antipsychotic medication (APM) as the frontline treatment for schizophrenia, its use remains a controversial topic, and nonadherence rates range between 40% and 60%. At the heart of the debate lies a divergence of views about the tradeoffs between side effects and efficacy, particularly over the long term. This Open Forum describes a series of challenges pertaining to the conceptualization and operationalization of APM use. The authors suggest pragmatic recommendations oriented toward shifting the dialogue from often-polarized positions about APM to a transformed research culture prioritizing service users' choices about diverse utilization patterns.
Original language | American English |
---|---|
Pages (from-to) | 1464-1466 |
Number of pages | 3 |
Journal | Psychiatric Services |
Volume | 72 |
Issue number | 12 |
DOIs | |
State | Published - 1 Dec 2021 |
Keywords
- Adherence
- Antipsychotics
All Science Journal Classification (ASJC) codes
- Psychiatry and Mental health